BCRX icon

BioCryst Pharmaceuticals
BCRX

Overview Fund Activity

234 hedge funds and large institutions have $1.87B invested in BioCryst Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 42 funds opening new positions, 76 increasing their positions, 59 reducing their positions, and 26 closing their positions.

Holders
234
Holders Change
+13
Holders Change %
+5.88%
% of All Funds
4.05%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
42
Increased
76
Reduced
59
Closed
26
Calls
$54.3M
Puts
$18M
Net Calls
+$36.2M
Net Calls Change
+$11.7M

Top Buyers

1
ACA
1
Avoro Capital Advisors
New York
$114M
2
GKIM
2
GW&K Investment Management
Massachusetts
$17.9M
3
Two Sigma Investments
3
Two Sigma Investments
New York
$13M
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$71.9M
5
D.E. Shaw & Co
5
D.E. Shaw & Co
New York
$6.24M

Top Sellers

1
Morgan Stanley
1
Morgan Stanley
New York
$11.5M
2
State Street
2
State Street
Massachusetts
$118M
3
PAMS
3
Pictet Asset Management (Switzerland)
Switzerland
$60.7M
4
Victory Capital Management
4
Victory Capital Management
Texas
$44.4M
5
Adage Capital Partners
5
Adage Capital Partners
Massachusetts
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
GKIM
26
GW&K Investment Management
Massachusetts
$17.9M +$17.9M +1,417,140 New
SCM
27
Sarissa Capital Management
Connecticut
$17.5M – – –
Charles Schwab
28
Charles Schwab
California
$17.5M +$367K +29,145 +2%
Millennium Management
29
Millennium Management
New York
$16.7M -$7.84M -622,153 -32%
Balyasny Asset Management
30
Balyasny Asset Management
Illinois
$15.4M +$368K +29,210 +2%
TCM
31
Tang Capital Management
California
$15.1M – – –
Norges Bank
32
Norges Bank
Norway
$13.5M -$11.5M -912,249 -46%
Two Sigma Investments
33
Two Sigma Investments
New York
$13M +$9.94M +788,618 +325%
Citadel Advisors
34
Citadel Advisors
Florida
$12.2M +$5.4M +428,854 +79%
Susquehanna International Group
35
Susquehanna International Group
Pennsylvania
$11.9M -$944K -74,947 -7%
Morgan Stanley
36
Morgan Stanley
New York
$11.5M -$43.7M -3,466,300 -79%
Bank of America
37
Bank of America
North Carolina
$10.8M +$1.16M +92,446 +12%
JPMorgan Chase & Co
38
JPMorgan Chase & Co
New York
$9.76M +$2.84M +225,163 +41%
ECM
39
ExodusPoint Capital Management
New York
$8.94M +$4.61K +366 +0.1%
Bank of New York Mellon
40
Bank of New York Mellon
New York
$8.46M +$649K +51,541 +8%
OIM
41
Oracle Investment Management
Connecticut
$8M +$393K +31,200 +5%
VOYA Investment Management
42
VOYA Investment Management
Georgia
$7.91M +$742K +58,879 +10%
MB
43
MPM BioImpact
Massachusetts
$7.63M -$421K -33,426 -5%
Osaic Holdings
44
Osaic Holdings
Arizona
$7.23M -$167K -13,230 -2%
Renaissance Technologies
45
Renaissance Technologies
New York
$7.12M +$5.53M +438,900 +347%
GTC
46
Ghost Tree Capital
New York
$6.62M +$2.52M +200,000 +62%
Ameriprise
47
Ameriprise
Minnesota
$6.54M +$3.41M +270,419 +109%
Rafferty Asset Management
48
Rafferty Asset Management
New York
$6.49M +$1.61M +127,901 +33%
PAM
49
Panagora Asset Management
Massachusetts
$6.33M +$1.47M +116,879 +30%
D.E. Shaw & Co
50
D.E. Shaw & Co
New York
$6.24M +$6.24M +495,539 New
1
2
3 4 5